Michigan Accelerator Fund 1
Michigan Accelerator Fund I is a venture capital investment partnership based in Grand Rapids, Michigan, with a fund size of $15.1 million. Established in 2010, the fund includes $6 million from the State of Michigan and over $9 million from various individual and institutional investors. Its primary focus is on early-stage companies located within Michigan, particularly in the life sciences technology sector, while also targeting advanced manufacturing, homeland security, alternative energy technology, information technology, and agriculture. The fund aims to achieve long-term capital appreciation for its investors while contributing to the economic growth of Michigan.
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension. Its technology involves endovascular catheters to provide an efficacious, durable, cost-effective, and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.
Vestaron is leading a peptide-based revolution in crop protection. The company is committed to providing growers with novel, effective, peptide-based biopesticides that address proven targets. Vestaron's peptides overcome existing resistance issues while offering a desired safety profile for workers, beneficial, and the environment. Vestaron has earned global recognition for its work, including the inaugural 2015 Bernard Blum Award for novel biocontrol solutions, the prestigious Green Chemistry Challenge Award from the U.S. Environmental Protection Agency and the American Chemical Society Green Chemistry Institute in 2020, and Best New Biologic Product in the 2021 Crop Science Awards.
Swift Biosciences, Inc. develops molecular biology reagents for research and diagnostic applications. Swift Biosciences, Inc. is based in Ann Arbor, Michigan.
eAgile designs, manufactures, and distributes customized RFID products in UHF, HF, NFC, LF, and in a wide variety of form factors.The company's ability to innovate with purpose has led to the continual expansion of its facilities, capabilities, and products. Today, eAgile operates out of a 40,000 square foot, ISO-certified facility complete with testing and demonstration centers, and offers a broad range of RFID tags (UHF, HF/NFC, LF) with customized hardware and software solutions. eAgile continues to innovate to propel market improvement and to ensure each product and system fulfills its purposes based on the needs of the client.
nanoRETE, Inc. develops field-operable nanoparticle-based biosensors for the rapid diagnosis of infections disease agents. The company focuses on pathogen and toxin detection within the food safety and supply markets. Its handheld point-of-care biosensors are used in public health, homeland defense, food supply chain, and economic infrastructures. nanoRETE, Inc. was founded in 2011 and is based in Lansing, Michigan.
Vestaron is leading a peptide-based revolution in crop protection. The company is committed to providing growers with novel, effective, peptide-based biopesticides that address proven targets. Vestaron's peptides overcome existing resistance issues while offering a desired safety profile for workers, beneficial, and the environment. Vestaron has earned global recognition for its work, including the inaugural 2015 Bernard Blum Award for novel biocontrol solutions, the prestigious Green Chemistry Challenge Award from the U.S. Environmental Protection Agency and the American Chemical Society Green Chemistry Institute in 2020, and Best New Biologic Product in the 2021 Crop Science Awards.
Vestaron is leading a peptide-based revolution in crop protection. The company is committed to providing growers with novel, effective, peptide-based biopesticides that address proven targets. Vestaron's peptides overcome existing resistance issues while offering a desired safety profile for workers, beneficial, and the environment. Vestaron has earned global recognition for its work, including the inaugural 2015 Bernard Blum Award for novel biocontrol solutions, the prestigious Green Chemistry Challenge Award from the U.S. Environmental Protection Agency and the American Chemical Society Green Chemistry Institute in 2020, and Best New Biologic Product in the 2021 Crop Science Awards.
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension. Its technology involves endovascular catheters to provide an efficacious, durable, cost-effective, and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.